News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

University of British Columbia Innovation is Advanced by the Centre for Drug Research and Development and Licensed by Global Healthcare Company


11/29/2010 9:20:16 AM

VANCOUVER, British Columbia--(BUSINESS WIRE)--The University of British Columbia (UBC) and the Centre for Drug Research and Development (CDRD) today announced that Covidien, a leading global provider of healthcare products, has licensed an innovative drug-delivery platform technology invented by UBC researcher, Pieter Cullis. This transaction represents the first successful licensing agreement of a technology jointly developed between a UBC researcher and the full drug development platform available at CDRD.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES